Search results
Results from the WOW.Com Content Network
The 5-year disease-free survival for age >5 years is 50-60%. [63] Another report found a similar 5-year survival at about 65% with 51% progression-free survival. [64] The 10-year disease-free survival is 40-50%. Younger ages showed lower 5 and 10-year survival rates. [63]
An ependymoma is a tumor that arises from the ependyma, a tissue of the central nervous system. Usually, in pediatric cases the location is intracranial , while in adults it is spinal . The common location of intracranial ependymomas is the floor of the fourth ventricle .
A subependymoma is a type of brain tumor; specifically, it is a rare form of ependymal tumor. [1] They are usually in middle aged people. Earlier, they were called subependymal astrocytomas.
Human infectious diseases may be characterized by their case fatality rate (CFR), the proportion of people diagnosed with a disease who die from it (cf. mortality rate).It should not be confused with the infection fatality rate (IFR), the estimated proportion of people infected by a disease-causing agent, including asymptomatic and undiagnosed infections, who die from the disease.
The ependyma is the thin neuroepithelial (simple columnar ciliated epithelium) lining of the ventricular system of the brain and the central canal of the spinal cord. [1] The ependyma is one of the four types of neuroglia in the central nervous system (CNS).
Survival rates for most childhood cancers have improved, with a notable improvement in acute lymphoblastic leukemia (the most common childhood cancer). Due to improved treatment, the 5-year survival rate for acute lymphoblastic leukemia has increased from less than 10% in the 1960s to about 90% during the time period 2003-2009.
The Collaborative Ependymoma Research Network (CERN) Foundation is a nonprofit organization composed of scientists and adult and pediatric cancer researchers who work together to develop new treatments for ependymoma, a type of primary brain or spinal cord tumor that occurs in both children and adults, and improve the outcomes and care of patients. [1]
Survival rate is a part of survival analysis.It is the proportion of people in a study or treatment group still alive at a given period of time after diagnosis. It is a method of describing prognosis in certain disease conditions, and can be used for the assessment of standards of therapy.